<DOC>
	<DOCNO>NCT02436980</DOCNO>
	<brief_summary>OBJECTIVE : Purpose study set forth sedative efficacy effect early period cognitive function two premedication drug use ERCP ( Endoscopic retrograde cholangiopancreatography ) METHODS : This randomize double blind study perform forty ( 18-70 age ) ASA I-III risk group patient elective ERCP plan . Cognitive function patient determine mini-mental test ( MMT ) . 0.5 mg/kg midazolam 1mg/kg tramadol drop administer orally intervention patient randomly divide two premedication group . Vital sign , BIS ( Bispectral index ) , mRSS ( modify Ramsay Sedation scale ) , NRS ( numeric rating scale ) evaluate . If MMT ( mini-mental test ) ≤ 23 60th minute consider cognitive impairment . Recovery period , post-procedure state cognitive function 60th minute record .</brief_summary>
	<brief_title>Premedication ERCP With Midazolam Tramadol</brief_title>
	<detailed_description>The Outcome Measures number Participants Adverse Events , incidence Postoperative cognitive dysfunction assess MMT ( mini-mental test ) first 60 minute .</detailed_description>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>This study conduct Endoscopy Department forty ( 1870 year old ) outpatients ASA IIII risk group randomize double blind plan elective ERCP . American Society Anesthesiologist ( ASA ) class great 3 , morbid obesity , major organ dysfunction ( respiratory , renal hepatic ) , history drug addiction , know hypersensitivity tramadol , midazolam remifentanil , minimental test ( MMT ) ≤ 23 refusal patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>premedication</keyword>
	<keyword>ERCP</keyword>
	<keyword>midazolam</keyword>
	<keyword>tramadol</keyword>
	<keyword>cognitive</keyword>
</DOC>